Candriam Luxembourg S.C.A. »

Eyepoint Pharmaceuticals shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.2M 140k 23.11

More positions owned by Candriam Luxembourg S.C.A.

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Merck & Co (MRK)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Amgen (AMGN)
Regeneron Pharmaceuticals (REGN)
Visa Com Cl A (V)
Gilead Sciences (GILD)
Amazon (AMZN)
Mastercard Incorporated Cl A (MA)
Procter & Gamble Company (PG)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Franklin Resources
T. Rowe Price Associates
Vanguard Group
Citadel Advisors
Perceptive Advisors
Millennium Management
Ikarian Capital
Deutsche Bank Aktiengesellschaft
Federated Investors
Fiera Capital Corporation
Laurion Capital Management
UBS Group
Goldman Sachs Group
Oracle Investment Management

View all funds holding Eyepoint Pharmaceuticals